Trademark: 88229094
Word
TARZIFYX
Status
Dead
Status Code
606
Status Date
Monday, February 17, 2020
Serial Number
88229094
Mark Type
4000
Filing Date
Thursday, December 13, 2018
Published for Opposition
Tuesday, May 21, 2019
Abandoned Date
Monday, February 17, 2020

Trademark Owner History
AADi Bioscience, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular disease, epilepsy and mitochondrial disease; vaccine preparations; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in in pediatric, geriatric, emergency, family, and human preventative medicine; Pharmaceutical preparations for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease
42 Medical and pharmaceutical research services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, scientific research services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific research and technological services consultation services in the field of development, manufacturing and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific research and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical and chemical products; providing evaluation testing for pharmaceutical, biopharmaceutical and chemical products, and medical devices featuring testing for safety, toxicity, content, identity, purity, configuration and function for others, using chemical, in vitro or in vivo assays, analyses and models; pre-clinical and non-clinical evaluation testing of pharmaceutical, biopharmaceutical and chemical products performed primarily using animals and other biological models; pharmaceutical, biopharmaceutical, and chemical research and development for others; pharmaceutical research in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical research for use in pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical research for the treatment of infectious, deficiency, hereditary, and physiological diseases

Trademark Events
Feb 18, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 17, 2020
Abandonment - No Use Statement Filed
Jul 16, 2019
Noa E-Mailed - Sou Required From Applicant
May 21, 2019
Official Gazette Publication Confirmation E-Mailed
May 21, 2019
Published For Opposition
May 1, 2019
Notification Of Notice Of Publication E-Mailed
Apr 12, 2019
Assigned To Lie
Mar 25, 2019
Approved For Pub - Principal Register
Mar 15, 2019
Examiner's Amendment Entered
Mar 15, 2019
Notification Of Examiners Amendment E-Mailed
Mar 15, 2019
Examiners Amendment E-Mailed
Mar 15, 2019
Examiners Amendment -Written
Mar 11, 2019
Assigned To Examiner
Jan 6, 2019
New Application Office Supplied Data Entered In Tram
Dec 17, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24